This article is brought to you in association with the European Parliament. The new law aims to avoid duplicating national assessments to determine a medicine’s added value that help EU countries decide on pricing and reimbursement. MEPs highlight that there are many barriers to accessing medicine and innovative technologies in the EU, the main ones being […]